– GSK Rolls Out 2D Barcodes For Vaccines in Program Designed to Improve Record Accuracy from MedCity News, reports following its participation in a pilot project by the Centers for Disease Control with Sanofi Pasteur, GlaxoSmithKline has become the second vaccine producer to roll out 2D barcodes as part of a program to improve the accuracy of vaccine immunization records

– Israeli biotech Compugen signed on to a collaboration with Bayer to find new antibody-based cancer immunotherapies. FierceBiotech’s Bayer Aims at Hot Cancer Immunotherapy Race with $540M R&D Deal outlines the recent development and Bayer’s goal to angle for a position in the hot cancer immunotherapy arena

– Roche and the Medicines Patent Pool signed an agreement to increase access to medicines to treat CMV infection in HIV-patients, a major cause of blindness. PharmaLive’s Roche, Medicines Patent Pool in Valcyte Agreement explains the agreement increases access to Valcyte, a key medicine to treat cytomegalovirus (CMV). CMV is a viral infection that can result in loss of vision and greater risk of death in people living with HIV. 

– Medical Marketing Media’s Merck Buys Controlling Stake in Physicians Interactive shares the news that Merck’s Global Health Innovation Fund (GHIF) has taken a controlling interest in digital physician marketing firm Physicians Interactive, deepening its relationship with a well-established provider of non-personal promotion to HCPs

– Boehringer Ingelheim recently held a research and development day to provide an update on progress in its key disease areas. Pharmaphorum caught up with Dr. Victoria Zazulina, Global Clinical Programme Team Leader for Oncology, to find out about the company’s expansion into this therapeutic area in Boehringer Ingelheim Focuses on Oncology, Personalized Medicine and Patient Support